Search results

Page results

• Biatain® dressings for radiotherapy and proton beam therapy skin reactions

  Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.

• National roll-out of Child Houses to support victims of sexual abuse announced at UCLH’s Lighthouse

  Wes Streeting, health and social care secretary, and Jess Phillips, minister for safeguarding, joined Sadiq Khan, mayor of London, and Kaya Comer-Schwartz, deputy mayor for policing and crime, at UCLH’s Lighthouse to announce a national roll-out of Child Houses to all NHS regions.

• Aftercare Guidance Following an Intrathecal Baclofen Pump Implant

  Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.

• Professor Manjit Matharu

  Professor Manjit Matharu's major research interests include migraine, trigeminal autonomic cephalalgias, facial pain, neurostimulation for intractable headaches, spontaneous intracranial hypotension and other headache disorders in hypermobility syndromes.

• Guide to managing an IBD Flare: My Crohn’s and Ulcerative Colitis

  This page explains what to do if you think your IBD symptoms have returned and who to contact for support.

• Preterm babies do not habituate to repeated pain

  Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.

• Molecular Radiotherapy Series No.6 – Information for parents of children and young people having radioactive iodine (131I) treatment

  This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment.

• UCLH recruits first patient globally for new Alzheimer’s Disease trial

  UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.

• Steroid treatment for inflammation caused by immunotherapy

  This information is for patients receiving steroids for immunotherapy toxicity.

• Cancer immunotherapy treatment

  This page is for cancer patients receiving immunotherapy treatment.